டக்ளஸ் கிராகவர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டக்ளஸ் கிராகவர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டக்ளஸ் கிராகவர் Today - Breaking & Trending Today

A little blue pill that protects you from HIV — if you use it


Much has changed for the better since the peak of the HIV/AIDS epidemic in the mid-1980s. The number of new annual HIV infections is less than one-third of what it was. In addition, more HIV-prevention drugs are reaching the marketplace and giving consumers options beyond Truvada, which was approved by the Food and Drug Administration in 2012 and is close to 99% effective when taken daily, as prescribed.
PrEP is a HIV-prevention strategy, which requires a HIV-negative person to take medication. It is “one of the most important tools we have to end the HIV epidemic in the U.S. and around the globe,” says Dr. Douglas Krakower, an infectious disease specialist at Boston’s Beth Israel Deaconess Medical Center. An acronym for pre-exposure prophylaxis, “PrEP is highly effective. It’s very safe in the vast majority of people who use it.” ....

New York , United States , Douglas Krakower , Centers For Disease , Institute Of Medicine , While The World Health Organization , Us Department Of Health , Human Services , Drug Administration , Boston Beth Israel Deaconess Medical Center , Beth Israel Deaconess Medical , World Health Organization , Kevin Robert Frost , Disease Control , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , டக்ளஸ் கிராகவர் , மையங்கள் க்கு நோய் , நிறுவனம் ஆஃப் மருந்து , போது தி உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , எங்களுக்கு துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , போஸ்டன் பெத் இஸ்ரேல் டேப்ககோணேஸ் மருத்துவ மையம் , பெத் இஸ்ரேல் டேப்ககோணேஸ் மருத்துவ , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , கெவின் ராபர்ட் பனி ,

Successful Pilot Integrates PrEP and Syringe Exchange Services | Now


December 16, 2020
A new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV.
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effectiveway to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University’s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the  ....

United States , University Of Pennsylvania , Silvana Mazzella , Josea Benitez , Nguyenk Tran , Douglass Krakower , Scarlettl Bellamy , Marisaa Felsher , Brogan Piecara Rachel Fox , Annetteb Gadegbeku , Alexis Roth , Centers For Disease , Syringe Exchange Services To Increase Arsenal , National Institute On Drug Abuse , Drexel University Dornsife School Of Public Health , Harvard Medical School , Sexual Health Equity Project , University Of Alabama At Birmingham , University Of Michigan , Dornsife School Of Public Health , Successful Pilot Integrates , Syringe Exchange Services , Increase Arsenal , Women Who Inject , Disease Control , Drexel University ,

Successful pilot integrates PrEP and syringe exchange services


 E-Mail
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effective way to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
Journal of Acquired Immune Deficiency Syndrome.
In the first demonstration project among women who inject drugs, known as Project Sexual Health Equity (Project SHE), the team prescribed up to 24 weeks of daily PrEP, to 95 adult cisgender women those whose gender identity matches their sex assigned at birth. The study was based at the largest syringe services program in the mid-Atlantic Prevention Point Philadelphia loca ....

United States , University Of Pennsylvania , Atlantic Point , Silvana Mazzella , Josea Benitez , Nguyenk Tran , Douglass Krakower , Scarlettl Bellamy , Marisaa Felsher , Brogan Piecara Rachel Fox , Annetteb Gadegbeku , Alexis Roth , Centers For Disease , National Institute On Drug Abuse , Drexel University Dornsife School Of Public Health , Harvard Medical School , Sexual Health Equity Project , University Of Alabama At Birmingham , University Of Michigan , Dornsife School Of Public Health , Disease Control , Drexel University , Dornsife School , Public Health , Acquired Immune Deficiency , Sexual Health Equity ,